Many women wonder whether birth control pills that help with weight loss exist, or if certain contraceptive pills affect body weight. Current evidence shows that no contraceptive pill is clinically proven to cause weight loss, and most combined oral contraceptive pills (COCPs) do not cause significant weight gain. Whilst some women experience temporary fluid retention or bloating when starting hormonal contraception, these effects typically resolve within a few months. Understanding how different pill formulations work, and which options may minimise weight-related concerns, can help you make an informed choice about contraception that suits your individual health needs and lifestyle.
Summary: No contraceptive pill is clinically proven to cause weight loss, and most combined oral contraceptive pills do not cause significant weight gain in users.
- Combined oral contraceptive pills contain oestrogen and progestogen; lower-dose formulations (20–30 micrograms ethinylestradiol) may reduce fluid retention.
- Progestogens with anti-mineralocorticoid properties, such as drospirenone, may counteract bloating in some users but carry slightly higher VTE risk.
- Temporary fluid retention in the first few months of use can create a sensation of weight increase, though this typically resolves as the body adjusts.
- Depot medroxyprogesterone acetate (DMPA) injection has been more consistently associated with weight gain than oral contraceptive pills.
- Contraceptive choice should be individualised based on medical eligibility (UKMEC), efficacy, side-effect profile, and personal preferences rather than weight concerns alone.
- Women experiencing rapid or unexplained weight gain should consult their GP to exclude other causes such as thyroid dysfunction or polycystic ovary syndrome.
Table of Contents
Am I eligible for weight loss injections?
Find out whether you might be eligible!
Answer a few quick questions to see whether you may be suitable for prescription weight loss injections (like Wegovy® or Mounjaro®).
- No commitment — just a quick suitability check
- Takes about 1 minute to complete
Do Contraceptive Pills Cause Weight Gain or Loss?
The relationship between hormonal contraception and body weight remains one of the most frequently discussed concerns amongst women considering or using contraceptive pills. Current evidence does not support a direct causal link between combined oral contraceptive pills (COCPs) and significant weight gain. Systematic reviews, including Cochrane reviews and guidance from the Faculty of Sexual and Reproductive Healthcare (FSRH), have found that most women experience minimal weight changes when using combined pills, with any fluctuations typically attributable to normal variation rather than the contraceptive itself.
Some women do report subjective weight changes when starting hormonal contraception, but these experiences vary considerably between individuals. Fluid retention, particularly in the first few months of use, can create a temporary sensation of bloating or slight weight increase, though this typically resolves as the body adjusts to the hormonal changes. This effect may be associated with the oestrogen component of combined pills, though the clinical significance in most users is modest.
It is important to note that no contraceptive pill has been clinically proven to cause weight loss. Whilst some formulations may be associated with less fluid retention or fewer metabolic effects, they are not designed or licensed as weight management medications. The Medicines and Healthcare products Regulatory Agency (MHRA) does not recognise weight loss as a therapeutic indication for any contraceptive product. Women seeking contraception primarily for weight loss should be counselled about realistic expectations and offered evidence-based weight management support separately from contraceptive decision-making.
Factors such as age, lifestyle changes, dietary habits, and natural metabolic shifts often coincide with contraceptive use, making it challenging to isolate the pill's specific contribution to weight changes. A thorough discussion with a healthcare professional can help distinguish between perceived and actual weight changes and identify the most suitable contraceptive method based on individual health profiles and preferences. Women are encouraged to consult NHS contraception pages and FSRH patient information for further guidance.
Which Contraceptive Pills Are Less Likely to Affect Weight?
When selecting a contraceptive pill with minimal impact on weight, understanding the hormonal composition is essential. Combined oral contraceptive pills contain both oestrogen (typically ethinylestradiol) and a progestogen, whilst progestogen-only pills (POPs) contain only a progestogen component. The type and dose of these hormones may influence potential metabolic and fluid retention effects, though individual responses vary considerably.
Lower-dose oestrogen formulations (containing 20–30 micrograms of ethinylestradiol) may be associated with less fluid retention compared to higher-dose preparations, though robust evidence for clinically meaningful weight differences is limited. Examples include ethinylestradiol/desogestrel 20/150 microgram preparations (available under various brand names). These lower-dose pills maintain contraceptive efficacy whilst potentially reducing oestrogen-related side effects, including bloating and breast tenderness that some women interpret as weight gain.
The progestogen component also plays a role in how women experience their contraception. Newer-generation progestogens, such as drospirenone, possess mild anti-mineralocorticoid properties that may counteract fluid retention in some users. Ethinylestradiol/drospirenone combinations (available under various brand names) are sometimes preferred by women concerned about bloating, though evidence for significant weight differences remains limited. It is crucial to note that drospirenone-containing pills carry a slightly higher venous thromboembolism (VTE) risk compared to levonorgestrel-containing pills—approximately 9–12 cases per 10,000 women per year versus 5–7 cases per 10,000 women per year—and this must be factored into prescribing decisions according to UK Medical Eligibility Criteria for Contraceptive Use (UKMEC). Women with additional VTE risk factors (such as smoking over age 35, obesity, or personal history of VTE) require careful assessment before prescribing any combined hormonal contraceptive.
Progestogen-only pills, such as desogestrel 75 microgram or drospirenone 4 mg (where licensed and available), eliminate oestrogen entirely and may suit women who experience significant fluid retention with combined pills. However, individual responses vary considerably, and there is no conclusive evidence that POPs cause less weight change than COCPs on average.
The FSRH emphasises that contraceptive choice should be individualised, balancing efficacy, medical eligibility (UKMEC), side-effect profile, and personal preferences. Women concerned about weight should be reassured that most formulations have minimal impact, and switching between pills based solely on weight concerns is rarely necessary unless other side effects are problematic. Detailed information is available in the FSRH Combined Hormonal Contraception and Progestogen-only Pill guidelines.
How Hormonal Contraception Influences Metabolism and Appetite
Understanding the physiological mechanisms through which hormonal contraception might influence body weight requires examining potential effects on metabolism, appetite regulation, insulin sensitivity, and body composition. Oestrogen and progestogens exert complex effects on multiple metabolic pathways, though the clinical significance of these changes in healthy women is generally modest and variable.
Oestrogen may influence glucose metabolism and insulin sensitivity, with some studies suggesting combined oral contraceptives can cause mild changes in insulin resistance in susceptible individuals. However, in women without pre-existing metabolic conditions such as polycystic ovary syndrome (PCOS) or diabetes, these changes rarely translate into clinically significant weight gain. Oestrogen also affects lipid metabolism, though the clinical relevance of these changes in healthy users is usually limited.
The progestogen component may influence appetite and food intake, though evidence remains inconsistent and individual variation is substantial. Some women report increased appetite when taking certain progestogen-containing contraceptives, particularly depot medroxyprogesterone acetate (DMPA, Depo-Provera injection), which has been more consistently associated with weight gain than oral formulations. Studies suggest some DMPA users may gain 2–3 kg or more over the first year, with younger women and those with higher baseline BMI potentially at greater risk. Early weight gain in the first months may predict continued weight gain, and this should be discussed during counselling.
Fluid retention can cause temporary weight increases, typically stabilising after the first few cycles. This represents water weight rather than fat accumulation. Progestogens with anti-mineralocorticoid activity, such as drospirenone, may mitigate this effect in some users, though this is not a licensed indication.
Regarding body composition, high-quality studies have not demonstrated that hormonal contraception significantly alters fat distribution or lean muscle mass in most users. Any changes in body weight are more likely attributable to lifestyle factors, dietary intake, and physical activity levels rather than direct metabolic effects of the contraceptive.
For women with specific metabolic concerns—such as those with PCOS, diabetes, or obesity—individualised assessment is essential. FSRH guidance and UKMEC provide recommendations for contraceptive eligibility and any necessary monitoring in women with these conditions. Contraceptive choice should be guided by medical eligibility criteria rather than routine metabolic monitoring, which is not indicated solely for contraceptive use in healthy women.
Non-Pill Contraceptive Options and Weight Considerations
For women particularly concerned about potential weight effects, exploring non-oral hormonal and non-hormonal contraceptive methods provides valuable alternatives. Each method has distinct characteristics regarding hormonal exposure, efficacy, and reported weight effects.
Long-acting reversible contraception (LARC) methods are highly effective and recommended by NICE as first-line options for many women. The copper intrauterine device (Cu-IUD) contains no hormones and therefore has no direct metabolic or weight effects. This makes it an excellent choice for women wishing to avoid hormonal contraception entirely. The Cu-IUD provides highly effective contraception for 5–10 years depending on the model, with typical-use failure rates below 1%. Various brands are available.
The levonorgestrel intrauterine system (LNG-IUS) releases progestogen locally with lower systemic absorption than oral contraceptives, though systemic absorption does occur and systemic effects are possible. Whilst some women report weight changes with the LNG-IUS, systematic reviews have not confirmed significant average weight gain compared to non-hormonal methods. Various brands are available with different doses and durations of use (3–8 years). The lower systemic hormone levels compared to oral contraceptives may be advantageous for some women.
Depot medroxyprogesterone acetate (DMPA) injection, whilst highly effective, has been more consistently associated with weight gain than other methods. The FSRH recommends discussing this potential effect during counselling, particularly for adolescents and women with higher baseline BMI, as these groups may be at greater risk.
Barrier methods such as condoms are entirely hormone-free but require consistent use and have higher typical-use failure rates. The contraceptive implant (etonogestrel subdermal implant) releases progestogen systemically and, like other progestogen-only methods, shows variable effects on weight, with most studies finding no significant average change despite individual variation. Various brands are available.
Natural family planning and fertility awareness methods avoid all medications but require significant commitment, training, and have higher failure rates. Women should receive comprehensive counselling about all options, with decisions based on efficacy, medical eligibility (UKMEC), lifestyle factors, and personal preferences rather than weight concerns alone. Detailed information is available in the NICE Long-acting Reversible Contraception guideline and FSRH method-specific guidance.
Managing Weight While Taking Contraceptive Pills
For women using hormonal contraception who wish to maintain or achieve a healthy weight, evidence-based lifestyle strategies remain the cornerstone of weight management, with the contraceptive method playing a minimal role in most cases. A holistic approach addressing diet, physical activity, and behavioural factors is most effective.
Dietary modifications should focus on balanced nutrition rather than restrictive dieting. The NHS Eatwell Guide provides evidence-based recommendations including:
-
Consuming plenty of fruits, vegetables, and whole grains
-
Choosing lean proteins and reducing saturated fat intake
-
Limiting added sugars and highly processed foods
-
Maintaining adequate hydration, which can help distinguish between fluid retention and fat gain
-
Monitoring portion sizes and eating mindfully
Regular physical activity is essential for weight management and overall health. Current UK Chief Medical Officers' guidelines recommend at least 150 minutes of moderate-intensity activity or 75 minutes of vigorous-intensity activity weekly, plus strength training twice weekly. Exercise helps maintain metabolic rate, preserve lean muscle mass, and regulate appetite independently of contraceptive use.
Monitoring and self-awareness can help women distinguish between actual weight changes and perceived changes. Keeping a simple record of weight, dietary habits, and menstrual symptoms may reveal patterns and help identify whether the contraceptive or other factors are contributing to weight fluctuations. If significant or rapid weight gain occurs, consultation with a GP is advisable to exclude other causes such as thyroid dysfunction, polycystic ovary syndrome, or medication effects from other drugs.
For women experiencing persistent bloating or fluid retention, simple measures may help:
-
Reducing dietary sodium intake
-
Avoiding excessive caffeine and alcohol
-
Ensuring adequate sleep and stress management
-
Discussing with a healthcare provider whether switching to a lower-dose oestrogen pill might be appropriate, bearing in mind that any switch should consider medical eligibility (UKMEC) and VTE risk factors
When to seek medical advice: Women should contact their GP if they experience rapid or unexplained weight gain, severe bloating, or other concerning symptoms. Seek urgent same-day medical assessment (via NHS 111, your GP, or A&E as appropriate) if you develop:
-
Sudden severe chest pain
-
Sudden shortness of breath or difficulty breathing
-
Coughing up blood
-
Severe pain or swelling in one leg
-
Sudden severe headache or visual disturbance
These may indicate serious complications such as venous thromboembolism (blood clot) requiring immediate assessment.
For most women, maintaining healthy lifestyle habits whilst using their chosen contraceptive method will effectively support weight management goals without needing to change contraception. If you suspect you are experiencing a side effect from your contraceptive, report it via the MHRA Yellow Card Scheme (available online or via the Yellow Card app) and discuss with your healthcare provider. Further information is available on NHS contraception pages and from your GP or sexual health service.
Frequently Asked Questions
Can birth control pills help me lose weight?
No contraceptive pill is clinically proven or licensed to cause weight loss. Whilst some formulations may be associated with less fluid retention, they are designed for contraception, not weight management, and the MHRA does not recognise weight loss as a therapeutic indication for any contraceptive product.
Which birth control pill causes the least weight gain?
Lower-dose oestrogen pills (20–30 micrograms ethinylestradiol) and those containing drospirenone may be associated with less fluid retention in some women. However, current evidence does not support significant weight differences between most combined oral contraceptive pills, and individual responses vary considerably.
Why do I feel bloated on the pill?
Temporary fluid retention, particularly in the first few months of use, can create bloating or a slight weight increase due to the oestrogen component of combined pills. This effect typically resolves as your body adjusts to the hormonal changes, and reducing dietary sodium may help manage symptoms.
Is the copper coil better than the pill for avoiding weight gain?
The copper intrauterine device (Cu-IUD) contains no hormones and therefore has no direct metabolic or weight effects, making it an excellent choice for women wishing to avoid hormonal contraception entirely. It provides highly effective contraception for 5–10 years depending on the model.
Can I switch birth control pills if I've gained weight?
Switching pills based solely on weight concerns is rarely necessary unless other side effects are problematic, as most formulations have minimal impact on weight. A thorough discussion with your GP or sexual health service can help identify whether the pill or other factors (such as lifestyle changes or medical conditions) are contributing to weight changes.
What should I do if I gain a lot of weight suddenly on the pill?
Consult your GP if you experience rapid or unexplained weight gain to exclude other causes such as thyroid dysfunction, polycystic ovary syndrome, or medication effects from other drugs. Seek urgent same-day medical assessment if you develop sudden severe chest pain, shortness of breath, leg swelling, or severe headache, as these may indicate serious complications.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Heading 6
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
- Item 1
- Item 2
- Item 3
Unordered list
- Item A
- Item B
- Item C
Bold text
Emphasis
Superscript
Subscript
